BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 11133764)

  • 1. JAB/SOCS1/SSI-1 is an interleukin-2-induced inhibitor of IL-2 signaling.
    Sporri B; Kovanen PE; Sasaki A; Yoshimura A; Leonard WJ
    Blood; 2001 Jan; 97(1):221-6. PubMed ID: 11133764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
    Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M
    Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin-induced expression of cytokine-inducible SH2 signaling inhibitors in human hematopoietic progenitors.
    Cwikel S; Silvian-Drachsler I; Prolov L; Hooghe-Peters EL; Merchav S
    Exp Hematol; 2001 Aug; 29(8):937-42. PubMed ID: 11495699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new protein containing an SH2 domain that inhibits JAK kinases.
    Endo TA; Masuhara M; Yokouchi M; Suzuki R; Sakamoto H; Mitsui K; Matsumoto A; Tanimura S; Ohtsubo M; Misawa H; Miyazaki T; Leonor N; Taniguchi T; Fujita T; Kanakura Y; Komiya S; Yoshimura A
    Nature; 1997 Jun; 387(6636):921-4. PubMed ID: 9202126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressor of cytokine signaling 1/JAB and suppressor of cytokine signaling 3/cytokine-inducible SH2 containing protein 3 negatively regulate the signal transducers and activators of transcription signaling pathway in normal human epidermal keratinocytes.
    Yamasaki K; Hanakawa Y; Tokumaru S; Shirakata Y; Sayama K; Hanada T; Yoshimura A; Hashimoto K
    J Invest Dermatol; 2003 Apr; 120(4):571-80. PubMed ID: 12648219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of JAB/SOCS-1/SSI-1 and CIS3/SOCS-3/SSI-3 is involved in gp130 resistance in cardiovascular system in rat treated with cardiotrophin-1 in vivo.
    Hamanaka I; Saito Y; Yasukawa H; Kishimoto I; Kuwahara K; Miyamoto Y; Harada M; Ogawa E; Kajiyama N; Takahashi N; Izumi T; Kawakami R; Masuda I; Yoshimura A; Nakao K
    Circ Res; 2001 Apr; 88(7):727-32. PubMed ID: 11304496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mutant form of JAB/SOCS1 augments the cytokine-induced JAK/STAT pathway by accelerating degradation of wild-type JAB/CIS family proteins through the SOCS-box.
    Hanada T; Yoshida T; Kinjyo I; Minoguchi S; Yasukawa H; Kato S; Mimata H; Nomura Y; Seki Y; Kubo M; Yoshimura A
    J Biol Chem; 2001 Nov; 276(44):40746-54. PubMed ID: 11522790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Janus kinase inhibitor, JAB, is an interferon-gamma-inducible gene and confers resistance to interferons.
    Sakamoto H; Yasukawa H; Masuhara M; Tanimura S; Sasaki A; Yuge K; Ohtsubo M; Ohtsuka A; Fujita T; Ohta T; Furukawa Y; Iwase S; Yamada H; Yoshimura A
    Blood; 1998 Sep; 92(5):1668-76. PubMed ID: 9716595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressor of cytokine signaling 1 attenuates IL-15 receptor signaling in CD8+ thymocytes.
    Ilangumaran S; Ramanathan S; Ning T; La Rose J; Reinhart B; Poussier P; Rottapel R
    Blood; 2003 Dec; 102(12):4115-22. PubMed ID: 12907450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.
    Lejeune D; Demoulin JB; Renauld JC
    Biochem J; 2001 Jan; 353(Pt 1):109-116. PubMed ID: 11115404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and function of a new STAT-induced STAT inhibitor.
    Naka T; Narazaki M; Hirata M; Matsumoto T; Minamoto S; Aono A; Nishimoto N; Kajita T; Taga T; Yoshizaki K; Akira S; Kishimoto T
    Nature; 1997 Jun; 387(6636):924-9. PubMed ID: 9202127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three distinct domains of SSI-1/SOCS-1/JAB protein are required for its suppression of interleukin 6 signaling.
    Narazaki M; Fujimoto M; Matsumoto T; Morita Y; Saito H; Kajita T; Yoshizaki K; Naka T; Kishimoto T
    Proc Natl Acad Sci U S A; 1998 Oct; 95(22):13130-4. PubMed ID: 9789053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyrosine-phosphorylated SOCS-3 inhibits STAT activation but binds to p120 RasGAP and activates Ras.
    Cacalano NA; Sanden D; Johnston JA
    Nat Cell Biol; 2001 May; 3(5):460-5. PubMed ID: 11331873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CIS3 and JAB have different regulatory roles in interleukin-6 mediated differentiation and STAT3 activation in M1 leukemia cells.
    Suzuki R; Sakamoto H; Yasukawa H; Masuhara M; Wakioka T; Sasaki A; Yuge K; Komiya S; Inoue A; Yoshimura A
    Oncogene; 1998 Oct; 17(17):2271-8. PubMed ID: 9811457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CIS associates with the interleukin-2 receptor beta chain and inhibits interleukin-2-dependent signaling.
    Aman MJ; Migone TS; Sasaki A; Ascherman DP; Zhu Mh; Soldaini E; Imada K; Miyajima A; Yoshimura A; Leonard WJ
    J Biol Chem; 1999 Oct; 274(42):30266-72. PubMed ID: 10514520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of SHP1 and up-regulation of negative regulators of JAK/STAT signaling in HTLV-1 transformed cell lines and freshly transformed human peripheral blood CD4+ T-cells.
    Cheng J; Zhang D; Zhou C; Marasco WA
    Leuk Res; 2004 Jan; 28(1):71-82. PubMed ID: 14630083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressor of cytokine signaling 1 inhibits IL-10-mediated immune responses.
    Ding Y; Chen D; Tarcsafalvi A; Su R; Qin L; Bromberg JS
    J Immunol; 2003 Feb; 170(3):1383-91. PubMed ID: 12538698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SOCS-3 is tyrosine phosphorylated in response to interleukin-2 and suppresses STAT5 phosphorylation and lymphocyte proliferation.
    Cohney SJ; Sanden D; Cacalano NA; Yoshimura A; Mui A; Migone TS; Johnston JA
    Mol Cell Biol; 1999 Jul; 19(7):4980-8. PubMed ID: 10373548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of IL-2-induced Jak-STAT signaling by glucocorticoids.
    Bianchi M; Meng C; Ivashkiv LB
    Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9573-8. PubMed ID: 10920190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative regulation of cytokine signaling pathways.
    Yasukawa H; Sasaki A; Yoshimura A
    Annu Rev Immunol; 2000; 18():143-64. PubMed ID: 10837055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.